Clinical Trial Update: A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ZX008 (fenfluramine hydrochloride) as adjunctive therapy for Lennox-Gastaut syndrome has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Fenfluramine hydrochloride (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | Conditions: Lennox Gastaut Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2025-07-03